ReviewPlant cell reports2026
Regulatory architecture of high-altitude adaptation in Artemisia: from signal perception to specialized metabolism.
Review in Plant cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-altitude environments impose a multifactorial stress matrix, including cold, intense UV-B radiation, hypoxia, and drought, which demand integrated adaptive responses. The genus Artemisia exhibits coordinated phenotypic, physiological, and metabolic adaptations to altitude, collectively termed the Altitudinal Stress Syndrome. While recent work has established that this syndrome emerges from integration across genomic, physiological, metabolic, and architectural levels, the regulatory mechanisms coordinating this multi-level integration remain undefined. This review synthesizes molecular evidence from Artemisia to construct a testable framework for the regulatory architecture underlying altitude adaptation. We organize the known components into three functionally distinct levels: signal transducers (reactive oxygen species, calcium, hormones) that convert physical stress into biochemical information; signal integrators (hormonal crosstalk nodes, photoreceptor pathways) where convergent inputs combine; and transcriptional regulators (bHLH, MYB, WRKY families) that execute genome-wide reprogramming. The artemisinin biosynthetic pathway provides a well-mapped case study, revealing how cold signals propagate through AabHLH112 and AaERF1 to biosynthetic genes, how UV-B signals are transduced via AaHY5 and AaGSW1, and how AabHLH113 integrates jasmonate and abscisic acid signals. Competitive dimerization among bHLH factors creates tunable regulatory nodes, whereas epigenetic modifications at AaPAL1 may stabilize adaptive states. We critically evaluate evidence for each connection, distinguishing direct biochemical validation, genetic evidence, and correlational observations. This framework generates specific hypotheses about network architecture testable via genetic, biochemical, and systems-level approaches. By building upon the systems-level foundation of Altitudinal Stress Syndrome, this review advances our understanding from descriptive cataloging to a mechanistic and predictive model of plant adaptation to extreme environments.
Indexed as
Identifiers
42142290What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.